Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azacitidine for Molecular Relapse of Pediatric AML
DRKS00015449Phase 2Completed
- Sponsor
- GPOH
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 3
01
Overview
Phase 2, open-label, single-arm trial of azacitidine in acute myeloid leukemia (AML), sponsored by GPOH. Started Sep 2018; status: completed.
02
Drugs
azacitidine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on DRKS00015449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00015449.